MarketInOut Stock Screener Log In | Sign Up

Hanmi Pharmaceutical Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:30
Hanmi Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization5,748,168 mln
Float6.28 mln
Earnings Date10/29/2026

EPS

17,101
Exceptional

P / E

21.69
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.43
Borderline

1-Year Forecast

664,545
Transformational upside

Relative Strength

22 / 100
Significantly lagging

Business Description

Founded in 1973 and headquartered in Hwaseong-si, South Korea, Hanmi Pharm is a pharmaceutical company that develops and sells medicines across South Korea, China, Japan, the United States, and other markets. The company concentrates on areas where effective treatments are still lacking, such as weight management, metabolic conditions, cancer, and rare diseases. Among its offerings is Gugutams, a urology product that combines two active compounds to address both prostate enlargement and erectile dysfunction in a single treatment. Hanmi Pharm also works alongside MEDIC Life Sciences to advance cancer research through the identification of biological markers that could improve diagnosis and treatment.

Key Fundamentals

EPS17,101
P/E21.69
ROE17.32
RPS130,556
ROIC12.46
ROA10.08
Interest Cover19.25
EBITDA, mln400,293
EV / EBITDA16.30
EV / EBIT21.71
Revenue, mln1,655,478
EV / Revenue3.94

Quote Details

Last 369,500
Change 19000 (5.42%)
Open 355,000
Volume 111,540
Turnover 41,214,029,824
Average Volume 105,815

Financial Ratios

Pre-Tax Profit Margin17
Leverage Ratio1.66
Current Ratio1.82
Price / Book3.98
Price / Tangible Book4.37
Price / Cash Flow21.70
Price / Free Cash Flow29.26
Debt / Equity0.30
Price / Sales3.83
PEG Ratio1.36

Financial Strength

Altman Z-Score7.05
Piotroski F-Score 7 / 9
Beneish M-Score-2.43
Price to Intrinsic Value2.17
Price to Lynch Fair Value2.27
Price to Graham Number2.39
1-Year Target Price664,545
Shiller PE Ratio70.58

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.64% 42 / 100   
1 Month -28.94% 3 / 100   
2 Months -4.27% 51 / 100   
6 Months -26.69% 45 / 100   
1 Year 8.28% 72 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog